drugset / Trial / NCT00000225

Alternate-Day Buprenorphine Administration. Phase VI - 7

NCT00000225

Double-blindTreatment

Summary

The purpose of this study is to determine if four times a subject's daily maintenance dose will hold for 96 hours without changes in agonist and antagonist effects.

Timeline

Start
1992-12
Primary completion
Completion

Publications

  • Background patry, Bickel, Tzanis, Badger (in preparation). Every fourth day dosing with buprenorphine (1) A comparison of four schedules under blind-dosing procedures.. Patry, Bickel, Tzanis, Badger (in preparation). Every fourth day dosing with buprenorphine (1) A comparison of four different dosing schedules under blind-dosing procedures.

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified